Alivus Life Sciences standalone net profit rises 14.65% in the March 2026 quarter

Sales rise 6.09% to Rs 689.12 crore

Net profit of Alivus Life Sciences rose 14.65% to Rs 162.66 crore in the quarter ended March 2026 as against Rs 141.87 crore during the previous quarter ended March 2025. Sales rose 6.09% to Rs 689.12 crore in the quarter ended March 2026 as against Rs 649.55 crore during the previous quarter ended March 2025.

For the full year,net profit rose 16.24% to Rs 564.48 crore in the year ended March 2026 as against Rs 485.63 crore during the previous year ended March 2025. Sales rose 6.91% to Rs 2551.83 crore in the year ended March 2026 as against Rs 2386.88 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	689.12	649.55	6	2551.83	2386.88	7
OPM %	31.13	30.55	-	31.24	28.60	-
PBDT	236.00	207.27	14	852.32	714.74	19
PBT	215.80	191.30	13	776.96	654.13	19
NP	162.66	141.87	15	564.48	485.63	16

Powered by Capital Market - Live News